Innovation comes from all corners of the health industry, from big corporations to startups. According to Deloitte, the sector's developments focus on genetic sequencing apps to identify at-risk populations, 3D-printed devices, immunotherapy, artificial intelligence, point-of-care diagnostics, virtual reality, biosensors and trackers, telehealth and more. Nevertheless, the sector still faces limitations to reach a breakthrough: from traditional work systems and a pay-per-service model to regulatory limitations that slow innovation integration.

Mexico Health Review’s final chapter will include interviews with startups, venture capital firms, as well as companies investing in transforming the current state of the health provision. Disruption and visionary ideas are showcased, together with the best strategies to implement them.